<p>Peripheral Blood Platelet–Lymphocyte Ratio Is Good Predictor of Chemosensitivity and Prognosis in Gastric Cancer Patients</p>-Reference-Cited by-同舟云学术

Peripheral Blood Platelet–Lymphocyte Ratio Is Good Predictor of Chemosensitivity and Prognosis in Gastric Cancer Patients

Published:2020-02 Issue: Volume:Volume 12 Page:1303-1311
ISSN:1179-1322
Container-title:Cancer Management and Research
language:en
Short-container-title:CMAR

Author:

Ohe Yuka,Fushida Sachio^ORCID,Yamaguchi Takahisa,Kinoshita Jun,Saito Hiroto^ORCID,Okamoto Koichi,Nakamura Keishi,Tajima Hidehiro^ORCID,Ninomiya Itasu^ORCID,Ohta Tetsuo

Publisher

Informa UK Limited

Subject

Oncology

Reference43 articles.

1. A Comparison of Multimodality Treatment: Two or Four Courses of Paclitaxel plus Cisplatin or S-1 plus Cisplatin Followed by Surgery for Locally Advanced Gastric Cancer, a Randomized Phase II Trial (COMPASS)

2. Neoadjuvant chemotherapy with S-1 and cisplatin followed by D2 gastrectomy with para-aortic lymph node dissection for gastric cancer with extensive lymph node metastasis

3. Potential of extravasated platelet aggregation as a surrogate marker for overall survival in patients with advanced gastric cancer treated with preoperative docetaxel, cisplatin and S-1: a retrospective observational study

4. Metastasis-promoting role of extravasated platelet activation in tumor

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dysregulation of systemic immunity and its clinical application in gastric cancer;Frontiers in Immunology;2024-09-05

2. Outcomes associated with total neoadjuvant therapy with non-operative intent for rectal adenocarcinoma;Frontiers in Oncology;2024-07-29

3. Platelet-lymphocyte ratio predicts chemotherapy response and prognosis in patients with gastric cancer undergoing radical resection;Frontiers in Oncology;2024-03-06

4. Clinical significance of systemic inflammation response index and platelet–lymphocyte ratio in patients with adenocarcinoma of the esophagogastric junction and upper gastric cancer;Heliyon;2024-02

5. Predictors of Myelosuppression for Patients with Head and Neck Squamous Cell Carcinoma After Induction Chemotherapy;Clinical Medicine Insights: Oncology;2024-01